1.
Santos AP de T, Silva VCM, Mendes-Corrêa MC, Lemos MF, Malta F de M, Santana RAF, et al. Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis. Rev. Inst. Med. Trop. São Paulo [Internet]. 2022 Oct. 21 [cited 2024 Jun. 3];64:e61. Available from: https://journals.usp.br/rimtsp/article/view/203729